April 25 (Reuters) - Black Diamond Therapeutics Inc
BDTX.O :
* BLACK DIAMOND THERAPEUTICS ANNOUNCES PIPELINE
PRIORITIZATION AND
WORKFORCE REALIGNMENT
* BLACK DIAMOND THERAPEUTICS INC - COMPANY TO DISCONTINUE
DEVELOPMENT OF BDTX-189 AND REDUCE WORKFORCE TO EXTEND ITS CASH
RUNWAY INTO 3Q 2024
* BLACK DIAMOND THERAPEUTICS INC - STRATEGIC AREAS OF FOCUS
ON
DEVELOPMENT OF BDTX-1535 AND BDTX-4933
* BLACK DIAMOND THERAPEUTICS INC - DECIDED TO DISCONTINUE
DEVELOPMENT OF PROGRAM DUE TO RAPID EVOLUTION OF TREATMENT
LANDSCAPE IN NON-SMALL CELL LUNG CANCER
Source text for Eikon: ID:nGNX54T9rh
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com;))